Feriozzi Sandro, Torre Elena Sanz, Ranalli Teresa Valentina, Cardello Paolo, Morrone Amelia, Ancarani Enzo
Department of Nephrology and Dialysis, Florence, Italy.
Eur J Gastroenterol Hepatol. 2007 Feb;19(2):163-5. doi: 10.1097/MEG.0b013e32800fef46.
Fabry disease is an X-linked lysosomal storage disease caused by a deficiency of alpha-galactosidase A. This determines an accumulation of globotriaosylceramide within lysosomes. The clinical picture is highly variable and depends on cellular storage deposition. Renal, cardiac and nervous system are the most frequent organs involved. Gastrointestinal involvement is also present, associated with other clinical signs of Fabry disease and sometimes can be a prominent clinical manifestation. We describe a Fabry disease case in which gastrointestinal involvement was the first and the only clinical sign of Fabry disease and a diagnosis of Fabry disease was made by chance during a family screening. Enzyme replacement therapy was started and after 3 months, there was a complete disappearance of signs.
法布里病是一种由α-半乳糖苷酶A缺乏引起的X连锁溶酶体贮积病。这导致溶酶体内球三糖神经酰胺蓄积。临床表现高度多变,取决于细胞内的贮积沉积情况。肾脏、心脏和神经系统是最常受累的器官。胃肠道也会受累,与法布里病的其他临床体征相关,有时可能是突出的临床表现。我们描述了一例法布里病病例,其中胃肠道受累是法布里病的首个也是唯一临床体征,在一次家族筛查中偶然确诊为法布里病。开始酶替代治疗,3个月后体征完全消失。